Effects of lgm2605 on a primate model of asthma
AssigneesThe Trustees of the University of Pennsylvania, The Regents of the University of California
InventorsMelpo Christofidou-Solomidou, Angela Haczku
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods for treating asthma in a subject in need thereof comprising administering chemically synthesized secoisolaricirecinol diglucoside (SDG), and in particular, a racemic mixture of the SDG (LGM2605), stereoisomers thereof, metabolites thereof, and analogs thereof. Also provided are methods for treating or preventing ozone-induced damage in a subject in need thereof.
Claims24
A method for treating asthma in a human subject in need thereof, the method comprising:
- administering to the subject a therapeutically effective amount of chemically synthesized secoisolaricirecinol diglucoside (SDG).
(canceled)
(canceled)
(canceled)
-36. (canceled)
A method for treating ozone-induced damage in a human subject who has been or will be exposed to a dose of ozone, the method comprising:
- orally administering to the subject a therapeutically effective amount of chemically synthesized SDG.
-45. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.